Search

Displaying results 3861 - 3870 of 5451 in total
  1. Drug

    Coenzyme A

    go.drugbank.com/drugs/DB01992
    InvestigationalNutraceutical

    It is used as a supplement for the hypothetical treatment of acne. … All genomes sequenced to date encode enzymes that use coenzyme A as a substrate, and around 4% of cellular enzymes use it, or a thioester form of it, as a substrate.

  2. Drug

    Nordazepam

    go.drugbank.com/drugs/DB14028
    Investigational

    It may have actions similar to those of diazepam.

    Products: NORDAZ TABLET 15 mg
  3. Drug

    Trotabresib

    go.drugbank.com/drugs/DB17421
    Investigational

    Trotabresib is an oral, potent, and reversible inhibitor of the epigenetic target bromodomain and extra-terminal (BET) proteins.

    Synonyms: Bet inhibitor cc-90010
  4. Drug

    Agerafenib

    go.drugbank.com/drugs/DB15068
    Investigational

    Agerafenib is under investigation in clinical trial NCT03052569 (Expanded Access to RXDX-105 for Cancers With RET Alterations).

  5. Drug

    EC-0652

    go.drugbank.com/drugs/DB15340
    Experimental

    EC-0652 is under investigation in clinical trial NCT02202447 (Phase 1 of EC1169 In Patients With Recurrent MCRPC).

  6. Drug

    Adipiplon

    go.drugbank.com/drugs/DB06579
    Investigational

    It is known by the standardized identifier NG2-73.

  7. Drug

    Sparsomycin

    go.drugbank.com/drugs/DB04222
    Experimental

    It inhibits protein synthesis in 70S and 80S ribosomal systems. [PubChem]

  8. Drug

    Abivertinib

    go.drugbank.com/drugs/DB15327
    Investigational

    [L17383] It has been investigated for use in the treatment of non-small cell lung cancer (NSCLC) and B-cell malignancies. … once, it may provide more pronounced clinical benefits as compared to agents targeting single pathways (e.g. interleukin-6 inhibitors).

  9. Drug

    LP-2307

    go.drugbank.com/drugs/DB17470
    Experimental

    It was investigated for melanoma.

  10. Drug

    SMART101

    go.drugbank.com/drugs/DB18370
    Investigational

    SMART101 is an investigational cell therapy comprising human allogeneic CD34-CD7+ T cell progenitors that were cultured ex vivo.